Brian, Good question. I have started going to the multivim meetings on Mondays. I am interested in work to start bringing in southbound plugins to bring up VNFs on Azure and AWS. I understand the Azure work is in the queue. The AWS work has not started yet. In the far future we will also look at containerized VNFs but for now we should be able to plugin ARM and CloudFormation templates alongside the current HEAT ones - don't know if this work will make it in Beijing.
Btw, thank you for the Azure push a month ago - we started getting things rolling around the 20th of Dec and should receive our Azure subscription within the week. For now I occasionally run some personal account tests on azure to prep. /michael -----Original Message----- From: [email protected] [mailto:[email protected]] On Behalf Of Alexis de Talhouët Sent: Monday, January 22, 2018 09:48 To: BRIAN D FREEMAN <[email protected]> Cc: [email protected] Subject: Re: [onap-discuss] [OOM] DCAE status in non-openstack clouds ? Brian, DCAE deployment in Amsterdam is coupled to OpenStack cloud, and we’re not in the process of supporting other cloud for now. This could be an enhancement for Beijing, if DCAE still runs in VMs. And if we do such implementation, we should leverage Multicloud interfaces to do so. Prior to this, we should flush out the requirement of DCAE deployment on different type of cloud, what are the implications and so on. Alexis > On Jan 22, 2018, at 9:34 AM, FREEMAN, BRIAN D <[email protected]> wrote: > > Michale, Alexis, > > What is the current status of bring DCAE up on non-openstack clouds via OOM ? > I have gotten all components but DCAE to pass healthcheck but not sure > dcaegen2 pod is even starting in my Azure test environment. > > Brian > > -----Original Message----- > From: [email protected] > [mailto:[email protected]] On Behalf Of Michael > O'Brien via RT > Sent: Friday, January 05, 2018 2:46 PM > Cc: [email protected]; [email protected] > Subject: Re: [onap-discuss] [ONAP Helpdesk #50702] Unable to create > new JIRA on mandatory "Affects Version" introduced today > > Jessica, > Fixed - thank you > Verified task and bug creation > https://urldefense.proofpoint.com/v2/url?u=https-3A__jira.onap.org_bro > wse_INT-2D376&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx3DI5AoMgDmi2F > zw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=tKrU0djaLFNMunPe64U > L71aFWuRZOtZNphgsL0_tZww&e= > https://urldefense.proofpoint.com/v2/url?u=https-3A__jira.onap.org_bro > wse_INT-2D377&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx3DI5AoMgDmi2F > zw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=lmgLUdA1wy4X-hgZh5s > G7g92G3dUW8ZBiQIzON1dVIg&e= > > /michael > > -----Original Message----- > From: Jessica Wagantall via RT > [mailto:[email protected]] > Sent: Friday, January 5, 2018 13:38 > To: Michael O'Brien <[email protected]> > Cc: [email protected]; [email protected] > Subject: [ONAP Helpdesk #50702] Unable to create new JIRA on mandatory > "Affects Version" introduced today > > Dear Michael , > > Can you please try again. This mandatory field has now been isolated to only > Bug type issues on its own. Epic and Story can now be created without the > need of an Affected Version. > > Please try and let me know. > > Thanks and sorry for the trouble > Jess > > On Fri Jan 05 13:33:22 2018, jwagantall wrote: >> Working on this now.. >> >> thanks! >> Jess >> >> On Fri Jan 05 08:17:31 2018, [email protected] wrote: >>> Jessica, >>> Hi, JIRA currently is broken on the new validation field - we are >>> not able to add any new issues - could we get this addressed ASAP, >>> either temporarily reverse the change and retest it before >>> reintroducing it or temporarily auto-populating it >>> >>> Thank you >>> /michael >>> >>> -----Original Message----- >>> From: ONAP Helpdesk via RT [mailto:onap- >>> [email protected]] >>> Sent: Friday, January 5, 2018 00:44 >>> To: Michael O'Brien <[email protected]> >>> Subject: [ONAP Helpdesk #50702] AutoReply: Unable to create new JIRA >>> on mandatory "Affects Version" introduced today >>> >>> Greetings, >>> >>> Your support ticket regarding: >>> "Unable to create new JIRA on mandatory "Affects Version" >>> introduced today", has been entered in our ticket tracker. A >>> summary of your ticket appears below. >>> >>> If you have any follow-up related to this issue, please reply to >>> this email. >>> >>> You may also follow up on your open tickets by visiting >>> https://urldefense.proofpoint.com/v2/url?u=https-3A__rt.linuxfoundat >>> ion.org_&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx3DI5AoMgDmi2Fzw& >>> m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=FXckY0PVLNJI-0IyLaAM6k6lmgsRtC5iXouWEJ8SEcU&e= >>> -- if you have not logged into RT before, you will need to follow the >>> "Forgot your password" link to set an RT password. >>> >>> -- >>> The Linux Foundation Support Team >>> >>> >>> -------------------------------------------------------------------- >>> ----- >>> LF, >>> Hi, I totally agree with the new mandatory field "affects version" >>> - however I have tried adjusting the "configure fields" section and >>> an unable to raise any Epic or Story anymore because of the blocking >>> error on this field - which does not show on the create issue screen. >>> Setting the "Fix Version/s" field does not help. >>> Can you adjust the "Create Issue" screen so we can fill in this >>> mandatory field >>> >>> >>> [cid:[email protected]] >>> thank you >>> /Michael >>> >>> This message and the information contained herein is proprietary and >>> confidential and subject to the Amdocs policy statement, >>> >>> you may review at >>> https://urldefense.proofpoint.com/v2/url?u=https-3A__www.amdocs.com_ >>> about_email-2Ddisclaimer&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx >>> 3DI5AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=cwcQ >>> x-lb5lvCNmnJ6UvcPywCAUokSHPPUtuuEMBOiM8&e= >>> <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.amdocs.com >>> _about_email-2Ddisclaimer&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1eh >>> x3DI5AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=cwc >>> Qx-lb5lvCNmnJ6UvcPywCAUokSHPPUtuuEMBOiM8&e= > >>> >>> This message and the information contained herein is proprietary and >>> confidential and subject to the Amdocs policy statement, >>> >>> you may review at >>> https://urldefense.proofpoint.com/v2/url?u=https-3A__www.amdocs.com_ >>> about_email-2Ddisclaimer&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx >>> 3DI5AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=cwcQ >>> x-lb5lvCNmnJ6UvcPywCAUokSHPPUtuuEMBOiM8&e= >>> <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.amdocs.com >>> _about_email-2Ddisclaimer&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1eh >>> x3DI5AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=cwc >>> Qx-lb5lvCNmnJ6UvcPywCAUokSHPPUtuuEMBOiM8&e= > >> >> > > > > This message and the information contained herein is proprietary and > confidential and subject to the Amdocs policy statement, > > you may review at > https://urldefense.proofpoint.com/v2/url?u=https-3A__www.amdocs.com_ab > out_email-2Ddisclaimer&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx3DI5 > AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=cwcQx-lb5l > vCNmnJ6UvcPywCAUokSHPPUtuuEMBOiM8&e= > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.amdocs.com_a > bout_email-2Ddisclaimer&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1ehx3DI > 5AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=cwcQx-lb5 > lvCNmnJ6UvcPywCAUokSHPPUtuuEMBOiM8&e= > > > _______________________________________________ > onap-discuss mailing list > [email protected] > https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.onap.org_ma > ilman_listinfo_onap-2Ddiscuss&d=DwICAg&c=LFYZ-o9_HUMeMTSQicvjIg&r=e3d1 > ehx3DI5AoMgDmi2Fzw&m=X0h7lcMZUU83N2cuK_RLHtm5rKHLh_QVh7IVqQwuWl8&s=RxR > LDQIecOhG_dzWswNA19mVloRixnSnvKdyBDYaeLI&e= > _______________________________________________ > onap-discuss mailing list > [email protected] > https://lists.onap.org/mailman/listinfo/onap-discuss _______________________________________________ onap-discuss mailing list [email protected] https://lists.onap.org/mailman/listinfo/onap-discuss This message and the information contained herein is proprietary and confidential and subject to the Amdocs policy statement, you may review at https://www.amdocs.com/about/email-disclaimer <https://www.amdocs.com/about/email-disclaimer> _______________________________________________ onap-discuss mailing list [email protected] https://lists.onap.org/mailman/listinfo/onap-discuss
